72.56
price down icon8.90%   -8.27
 
loading

Billiontoone Inc Aktie (BLLN) Neueste Nachrichten

pulisher
12:31 PM

Wells Fargo & Company Has Lowered Expectations for Billiontoone (NASDAQ:BLLN) Stock Price - MarketBeat

12:31 PM
pulisher
10:51 AM

BTIG lowers BillionToOne stock price target on valuation multiples - Investing.com

10:51 AM
pulisher
09:48 AM

Billiontoone's (BLLN) "Buy" Rating Reiterated at Guggenheim - MarketBeat

09:48 AM
pulisher
09:16 AM

Billiontoone (NASDAQ:BLLN) Price Target Lowered to $140.00 at BTIG Research - MarketBeat

09:16 AM
pulisher
03:12 AM

BillionToOne Q4 2025 slides: profitability achieved amid 113% revenue surge By Investing.com - Investing.com Canada

03:12 AM
pulisher
01:16 AM

BillionToOne Swings To Profit In Q4; Lifts FY26 Guidance - Nasdaq

01:16 AM
pulisher
Mar 04, 2026

BillionToOne Q4 2025 slides: profitability achieved amid 113% revenue surge - Investing.com South Africa

Mar 04, 2026
pulisher
Mar 04, 2026

Billiontoone (NASDAQ:BLLN) Announces Earnings Results - MarketBeat

Mar 04, 2026
pulisher
Mar 04, 2026

Billiontoone Q4 Earnings Call Highlights - Yahoo Finance

Mar 04, 2026
pulisher
Mar 04, 2026

Earnings call transcript: BillionToOne’s Q4 2025 sees robust growth, stock dips - Investing.com India

Mar 04, 2026
pulisher
Mar 04, 2026

BillionToOne (BLLN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance

Mar 04, 2026
pulisher
Mar 04, 2026

BillionToOne Raises 2026 Guidance, Aligns Incentive Plan - TipRanks

Mar 04, 2026
pulisher
Mar 04, 2026

BillionToOne: Q4 Earnings Snapshot - marketscreener.com

Mar 04, 2026
pulisher
Mar 04, 2026

(BLLN) BillionToOne Expects 2026 Revenue Range $430M-$445M, vs. FactSet Est of $405.1M - marketscreener.com

Mar 04, 2026
pulisher
Mar 04, 2026

Earnings Flash (BLLN) BillionToOne Posts Q4 EPS $0.11, vs. FactSet Est of $0.06 - marketscreener.com

Mar 04, 2026
pulisher
Mar 04, 2026

Earnings Flash (BLLN) BillionToOne, Inc. Reports Q4 Revenue $96.1M, vs. FactSet Est of $87.2M - marketscreener.com

Mar 04, 2026
pulisher
Mar 04, 2026

BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance - GlobeNewswire

Mar 04, 2026
pulisher
Mar 04, 2026

Billiontoone (NASDAQ:BLLN) Trading Down 5.7%Time to Sell? - MarketBeat

Mar 04, 2026
pulisher
Mar 04, 2026

BillionToOne Stock at $89: Why a New $19.1 Million Position Could Matter Now - AOL.com

Mar 04, 2026
pulisher
Mar 04, 2026

BillionToOne: Overview of Fourth Quarter Financial Results - Bitget

Mar 04, 2026
pulisher
Mar 03, 2026

Billiontoone (NASDAQ:BLLN) Trading Up 6%Time to Buy? - MarketBeat

Mar 03, 2026
pulisher
Mar 02, 2026

BillionToOne Inc expected to post earnings of 8 cents a shareEarnings Preview - TradingView

Mar 02, 2026
pulisher
Feb 27, 2026

BillionToOne (BLLN) Launches Two New Add-ons for Northstar Select - Yahoo Finance

Feb 27, 2026
pulisher
Feb 26, 2026

InvestingPro’s Fair Value spotted BillionToOne 46% drop in advance By Investing.com - Investing.com UK

Feb 26, 2026
pulisher
Feb 26, 2026

BLLN Should I Buy - Intellectia AI

Feb 26, 2026
pulisher
Feb 25, 2026

BLLN PE Ratio & Valuation, Is BLLN Overvalued - Intellectia AI

Feb 25, 2026
pulisher
Feb 24, 2026

BillionToOne Stock Slumps 13% in February. Analysts Still See $135 Fair Value - TIKR.com

Feb 24, 2026
pulisher
Feb 24, 2026

BillionToOne stock sinks 16% ahead of March earnings: what traders are watching - Bez Kabli

Feb 24, 2026
pulisher
Feb 23, 2026

Billiontoone (NASDAQ:BLLN) Reaches New 1-Year LowTime to Sell? - MarketBeat

Feb 23, 2026
pulisher
Feb 19, 2026

Five new option listings and three option delistings on February 19th - TipRanks

Feb 19, 2026
pulisher
Feb 18, 2026

Natera Accuses Worker Who Went to Competitor of Stealing Secrets - Bloomberg Law News

Feb 18, 2026
pulisher
Feb 17, 2026

BillionToOne to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026 - The Manila Times

Feb 17, 2026
pulisher
Feb 17, 2026

BillionToOne, Inc. Announces Q4 and Full Year 2025 Financial Results Release Date and Conference Call Details - Quiver Quantitative

Feb 17, 2026
pulisher
Feb 17, 2026

Oguzhan Atay reports 3.2M-share BillionToOne (BLLN) ownership stake - Stock Titan

Feb 17, 2026
pulisher
Feb 16, 2026

BillionToOne reaffirms FY25 guidance - MSN

Feb 16, 2026
pulisher
Feb 14, 2026

BillionToOne, Inc.Class A common stock (Nasdaq:BLLN) Stock Quote - The Chronicle-Journal

Feb 14, 2026
pulisher
Feb 14, 2026

Billiontoone, Inc. (NASDAQ:BLLN) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Feb 14, 2026
pulisher
Feb 12, 2026

BillionToOne adds pharmacogenomics, clonal filtering to Northstar cancer test - Mugglehead Investment Magazine

Feb 12, 2026
pulisher
Feb 11, 2026

BillionToOne expands liquid biopsy platform with two add-on tests By Investing.com - Investing.com Australia

Feb 11, 2026
pulisher
Feb 11, 2026

BillionToOne Expands Northstar Platform with Launch of Two New A - GuruFocus

Feb 11, 2026
pulisher
Feb 10, 2026

BillionToOne expands liquid biopsy platform with two add-on tests - Investing.com Nigeria

Feb 10, 2026
pulisher
Feb 10, 2026

BillionToOne Expands Northstar Platform with Launch of Two New Add-On Liquid Biopsy Applications for Northstar Select - Finviz

Feb 10, 2026
pulisher
Feb 10, 2026

BillionToOne, Inc. Expands Northstar Platform with Launch of Two New Add-On Liquid Biopsy Applications for Northstar Select - marketscreener.com

Feb 10, 2026
pulisher
Feb 10, 2026

BillionToOne Expands Northstar Platform with Launch of Two New Add-On Liquid Biopsy Applications for Northstar Select® - PR Newswire

Feb 10, 2026
pulisher
Feb 10, 2026

BillionToOne Announces Dual Launch of UNITY Expanded Red Blood Cell and Platelet Fetal Antigen NIPTs, Extending Its Leadership In Setting the New Standard in Prenatal Care - BioSpace

Feb 10, 2026
pulisher
Feb 10, 2026

BillionToOne initiated with a Hold at Jefferies - MSN

Feb 10, 2026
diagnostics_research DGX
$204.43
price down icon 1.93%
diagnostics_research LH
$275.79
price down icon 1.79%
diagnostics_research MTD
$1,262.84
price down icon 1.95%
$195.49
price down icon 3.75%
diagnostics_research IQV
$177.86
price down icon 0.07%
diagnostics_research WAT
$319.17
price up icon 0.03%
Kapitalisierung:     |  Volumen (24h):